4 studies found for:    19846844 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients
Conditions: Lymphoma;   Multiple Myeloma;   Myeloproliferative Disease
Intervention: Biological: Reassortant vaccine virus NYMC X-179A (New York Medical College, New York) derived form the A/california/7/2009 (H1N1) virus
2 Completed Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy
Conditions: Lymphoma;   Multiple Myeloma;   Influenza A Virus, H1N1 Subtype
Intervention: Biological: AS03-adjuvanted H1N1 pandemic influenza vaccine
3 Unknown  Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients
Conditions: Virus Diseases;   Respiratory Tract Diseases;   Respiratory Tract Infections;   Influenza;   Orthomyxoviridae Infections
Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg;   Other: blood fix
4 Completed Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older
Conditions: Virus Diseases;   Respiratory Tract Diseases;   Respiratory Tract Infections;   Influenza;   Orthomyxoviridae Infections
Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 30 μg;   Biological: Experimental: split-virion, adjuvanted H1N1 vaccine of 7.5 μg;   Biological: Experimental: split-virion, adjuvanted H1N1 vaccine of 15 μg;   Biological: Experimental: split-virion, adjuvanted H1N1 vaccine of 30 μg;   Biological: Experimental: split-virion, non-adjuvanted H1N1 vaccine of 15 μg;   Biological: Placebo Comparator: Placebo control

Indicates status has not been verified in more than two years